Becton Dickinson Joins Singapore Plan
Becton Dickinson Medical Products Pte Ltd has become the second health care company, after Baxter Healthcare, to join the Singapore Economic Development Board's local industry upgrading program.
The company, which has been producing hypodermic syringes and needles in Singapore since 1989, will assist the EDB in setting up a core group of supporting companies in key areas in the health care sector. It will second a senior manager under the LIUP scheme to help three Singapore companies - Flexible Automation Systems Pte Ltd, Hongguan Technologies Pte Ltd and Mold Technic Pte Ltd. More Singapore companies will be involved as the program progresses.
Launched in 1986, LIUP 's aim was originally to improve the overall efficiency of local suppliers. The program has since been expanded to include manufacturing and the joint development of new products and processes.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze